Health Trials

Early Atrial Fibrillation Ablation for Stroke Prevention in Patients With High Comorbidity Burden (EASThigh-AFNET 11)

ConditionAtrial Fibrillation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAtrial Fibrillation Network

About this trial

EASThigh-AFNET 11 is an international, prospective, randomized, open, blinded endpoint assessment, multicenter trial (Treatment Strategy trial).

The objective of EASThigh-AFNET 11 is to investigate whether early atrial fibrillation ablation in patients with atrial fibrillation (AF) and a high comorbidity burden (CHA2DS2-VASc ≥4) reduces cardiovascular events (stroke, cardiovascular death, or heart failure events) compared to usual care.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Early atrial fibrillation ablation
  • Usual Care

Treatment groups

2,312 Participants
are divided into 2 treatment groups

Locations

7

Map coordinates are unavailable for these locations. Locations are shown below instead.

Australia
Several sitesNot yet recruiting Multiple LocationsAustraliaAustralia
Canada
Several sitesRecruiting Multiple LocationsCanadaCanada
Germany
Several sitesRecruiting Multiple LocationsGermanyGermany
Netherlands
Several sitesRecruiting Multiple LocationsNetherlandsNetherlands

Sponsors and collaborators

Atrial Fibrillation Network

Lead sponsor

Source ClinicalTrials.gov